Dr. Ray is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
365 Lennon Ln
Ste 250
Walnut Creek, CA 94598Phone+1 925-943-6800Fax+1 925-943-6880
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1997 - 2000
Albert Einstein College of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 2003 - 2026
MA State Medical License 2000 - 2004- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Triple Therapy - PDT Plus IVD and Intravitreal Ranibizumab Versus Lucentis Monotherapy to Treat Age-Related Macular Degeneration Start of enrollment: 2006 Aug 01
- A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD Start of enrollment: 2008 Jan 01
Publications & Presentations
PubMed
- 22 citationsLuceDex: a prospective study comparing ranibizumab plus dexamethasone combination therapy versus ranibizumab monotherapy for neovascular age-related macular degeneration.Tushar M. Ranchod, Subhransu K. Ray, Stewart A. Daniels, Craig J. Leong, T. Daniel Ting
Retina. 2013-09-01 - 6 citationsAtypical manifestation of multiple evanescent white dot syndrome with large peripapillary lesion.Subhransu Ray, John I. Loewenstein
Archives of Ophthalmology. 2003-12-01 - 31 citationsVision-limiting complications in open-globe injuries.Manoj M. Thakker, Subhransu Ray
Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2006-01-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
